GLP‐1R‐expressing cells within the dorsal vagal complex, containing the NTS and AP, are necessary for the weight‐reducing effects of GLP‐1‐based obesity drugs.9, 19, 47. This evidence concerns the gene GLP1R and obesity disorder.